66.42USD-1.29%Mkt Cap: 2.30B $P/E: 15.201d ago
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company provides…
Indicators:|
Key Statistics
Company
Market Cap2.30B $
Enterprise Value2.70B $
Revenue (TTM)635.89M $
Gross Profit362.81M $
Net Income (TTM)190.29M $
Revenue/Share18.62 USD
Last Price66.42 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees898
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)15.20
P/E (Forward)20.76
PEG—
EV/EBITDA21.51
EV/Revenue4.24
P/S3.61
P/B4.64
EPS (TTM)4.37
EPS (Forward)3.20
52W Range
60.107% of range156.00
52W High156.00 USD
52W Low60.10 USD
Profitability
Gross Margin59.92%
Oper. Margin7.65%
EBITDA Margin19.71%
Profit Margin31.43%
ROE40.22%
ROA17.81%
Growth
Revenue Growth21.20%
Earnings Growth-71.50%
Cash Flow & Leverage
Operating CF192.84M $
CapEx (TTM)59.25M $
FCF Margin17.11%
FCF Yield4.74%
Net Debt401.68M $
Net Debt/EBITDA3.20
Balance Sheet
Debt/Equity1.10
Current Ratio6.74
Quick Ratio6.01
Book Value/Sh14.30 USD
Cash/Share13.36 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.7 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)117.33 USD
Upside (mean)+76.7%
Target Range80.00 USD – 142.00 USD
$80.00+76.7% to mean$142.00
# Analysts9
Ownership
Shares Out.34.56M
Float33.43M
Insiders3.43%
Institutions110.00%
Short Interest
Short Ratio6.3d
Short % Float34.66%
Short % Out.22.22%
Shares Short7.68M
Short (prev mo.)8.18M
Technical
SMA 5079.63 (-16.6%)
SMA 200114.07 (-41.8%)
Beta1.88
S&P 52W Chg20.05%
Avg Vol (30d)1.14M
Avg Vol (10d)1.28M
Technical Indicators
RSI (14)38.0
MACD-1.7708
MACD Signal-1.5538
MACD Hist.-0.2170
BB Upper79.97 USD
BB Middle72.85 USD
BB Lower65.74 USD
BB Width19.53%
ATR (14)4.695 USD
Vol Ratio (20d)1.24x